Keith Murphy
Executive Chairman, Director at VivoSim Labs, INC. (VIVS)
Keith Murphy has filed 12 insider reports with the SEC since March 2021, as director at Matinas BioPharma Holdings, Inc. (MTNB), executive Chairman and director at VivoSim Labs, INC. (VIVS) and director at Kintara Therapeutics, Inc. (HURA). The latest filing, on November 9, 2026, reports grant or award at Matinas BioPharma Holdings, Inc. (MTNB).
- Filings
- 12
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Keith Murphy is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2025 | $0.8557 | Nov 9, 2026 | |||||
| Executive Chairman, Director | 26,053 | $0.1201 | Jan 30, 2026 | ||||
| Director | $1.40 | Sep 23, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 6, 2026MTNBAmendment: Director Murphy Keith was granted 5,000 stock optionsForm 4Grant or award
- Nov 6, 2026MTNBDirector Murphy Keith was granted 5,000 stock optionsForm 4Grant or award
- Jan 27, 2026VIVSEXECUTIVE CHAIRMAN Murphy Keith was granted 15,000 shares, increasing direct ownership by 136% to 26,053 unitsForm 4Grant or award
- Apr 30, 2025MTNBSEC Form 4 filed by Director Murphy KeithForm 4Grant or award
- Mar 11, 2025MTNBKeith Murphy became an insiderForm 3New insider
- Aug 7, 2024VIVSEXECUTIVE CHAIRMAN Murphy Keith was granted 19,607 shares, increasing direct ownership by 17% to 132,641 unitsForm 4Grant or award
- Nov 17, 2023VIVSMurphy Keith was granted 19,607 shares, increasing direct ownership by 21% to 113,034 unitsForm 4Grant or award
- Nov 10, 2022VIVSSEC Form 4: Murphy Keith was granted 19,607 shares, increasing direct ownership by 27% to 93,427 unitsForm 4Grant or award
- Aug 31, 2022VIVSSEC Form 4 filed by Murphy KeithForm 4Grant or award
- Oct 7, 2021VIVSSEC Form 4 filed by Murphy KeithForm 4Grant or award
- Sep 22, 2021HURASEC Form 4 filed by Murphy KeithForm 4Grant or award
- Mar 8, 2021VIVSSEC Form 4: Keith Murphy was granted 20,000 units of Common Stock, increasing direct ownership by 43% to 66,320 unitsForm 4Grant or award
Compare Keith Murphy with
- Keith Murphy vs Adam K Stern2 shared
- Keith Murphy vs An Evelyn D1 shared
- Keith Murphy vs Edward Neugeboren1 shared
- Keith Murphy vs Tony Serge Lialin1 shared
- Keith Murphy vs James A. Bianco1 shared
- Keith Murphy vs Craig Tendler1 shared
Other insiders at the same companies
- James A. BiancoHURA
- An Evelyn DMTNB
- Edward NeugeborenMTNB
- Tony Serge LialinVIVS
- Adam K SternVIVS
- Sanitam Partners LLCMTNB
- Craig TendlerHURA
- George K NgHURA
- Manuso James S JHURA
- Alan ListHURA
- Robert E. HoffmanHURA
- Douglas Jay CohenVIVS
- Alison Tjosvold MilhousVIVS
- David GobelVIVS
- Dan DearbornHURA
- Amar Akhtar SethiVIVS
Questions about Keith Murphy
- What is Keith Murphy's role at VivoSim Labs, INC.?
- Keith Murphy reports to the SEC as executive Chairman and director at VivoSim Labs, INC. (VIVS), according to the latest filing on January 30, 2026. Keith Murphy has also filed as director at Matinas BioPharma Holdings, Inc. (MTNB) and director at Kintara Therapeutics, Inc. (HURA).
- How many shares does Keith Murphy own?
- After the latest filing that states it, Keith Murphy directly owned 26,053 shares of VivoSim Labs, INC. (VIVS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Keith Murphy bought or sold stock recently?
- No open-market purchases or sales by Keith Murphy are on file. The filings report grant or award.
- How do I get alerts when Keith Murphy files?
- Follow Keith Murphy on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Keith Murphy filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Keith Murphy (SEC CIK 0001536583). Totals count each trade once, skipping amendments whose original is on file, from Mar 10, 2021 on. View on SEC EDGAR